Related Experiment Video
Updated: Jan 16, 2026
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Benchmarking genetic interaction scoring methods for identifying synthetic lethality from combinatorial CRISPR
Hamda Ajmal1,2,3, Sutanu Nandi1,2,3,4, Narod Kebabci1,2,5
1Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, D04 V1W8, Ireland.
Abstract:
Synthetic lethality (SL) is an extreme form of negative genetic interaction, where simultaneous disruption of two non-essential genes causes cell death. SL can be exploited to develop cancer therapies that target tumour cells with specific mutations, potentially limiting toxicity. Pooled combinatorial CRISPR screens, where two genes are simultaneously perturbed and the resulting impacts on fitness estimated, are now widely used for the identification of SL targets in cancer. Various scoring methods have been developed to infer SL genetic interactions from these screens, but there has been no systematic comparison of these approaches. Here, we performed a comprehensive analysis of five scoring methods for SL detection using five combinatorial CRISPR datasets. We assessed the performance of each algorithm on each screen dataset using two different benchmarks of paralog SL. We find that no single method performs best across all screens but identify two methods that perform well across most datasets. Of these two scores, Gemini-Sensitive has an available R package that can be applied to most screen designs, making it a reasonable first choice.
Insights
Synthetic lethality (SL) involves disrupting two genes to kill cancer cells. This study compares five methods for identifying SL interactions from CRISPR screens, finding two top performers, including Gemini-Sensitive.
Area of Science:
- Genetics
- Genomics
- Cancer Biology
Background:
- Synthetic lethality (SL) is a genetic interaction where disabling two non-essential genes causes cell death.
- SL strategies offer targeted cancer therapies by exploiting tumor-specific mutations, potentially reducing side effects.
- Pooled combinatorial CRISPR screens are crucial for identifying SL targets in cancer research.
Purpose of the Study:
- To systematically compare the performance of five different scoring methods for detecting synthetic lethality from CRISPR screens.
- To evaluate these methods across multiple CRISPR datasets and identify robust approaches for SL target discovery.
Main Methods:
- Conducted a comprehensive analysis of five scoring algorithms for synthetic lethality detection.
- Utilized five independent combinatorial CRISPR screen datasets for evaluation.
- Assessed algorithm performance using two distinct benchmarks of paralog synthetic lethality.
Main Results:
- No single scoring method consistently outperformed others across all tested CRISPR screen datasets.
- Identified two scoring methods that demonstrated strong performance across the majority of datasets.
- The Gemini-Sensitive score, with an available R package, was highlighted as a practical choice for various screen designs.
Conclusions:
- The choice of scoring method significantly impacts synthetic lethality detection in CRISPR screens.
- Gemini-Sensitive and another method show promise for reliable SL target identification across diverse datasets.
- The availability of user-friendly tools like the Gemini-Sensitive R package facilitates the application of these methods in cancer research.
